drugset / Trial / NCT02654717

Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp

NCT02654717 ↗

Phase 2 Completed 111 enrolled Promius Pharma, LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to see how well DFD-07 works in treating actinic keratosis on the face and scalp during 8 weeks of treatment. The study will also look at any unwanted effects of the study drug.

Timeline

Start
2015-11
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject DFD07 Unknown — Topical

Indications